10月20日 - ** Metis TechBio（7666.HK）股价上涨6.5%，至12.69港元，创下自10月13日以来的最高水平
** 这家中国人工智能驱动的纳米材料平台技术开发商周一表示，已与礼来公司（Eli Lilly） LLY.N 签署了一项合作协议 (link)
** 该协议价值高达11亿美元，旨在研发组织特异性药物递送技术
** Metis将利用其专有的AI驱动药物递送平台，开发旨在改善基于脂质纳米颗粒（LNP）的药物到达靶向组织效率的下一代技术
** 自5月13日上市以来，Metis股价较每股10.50港元的发行价上涨了13.3%
** 今年以来，恒生生物科技指数 .HSBIO 上涨4.3%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.